GAAP EPS was $(0.49) for Q2 2025, missing analyst estimates by 22.3%. Moleculin Biotech (NASDAQ:MBRX), a clinical-stage pharmaceutical developer focused on oncology, released its second quarter 2025 ...

That hint prompted a Tuesday question from The Dallas Morning News and a candid, newsworthy response from Cowboys owner Jerry Jones: He fought stage 4 melanoma for a decade and an experimental trial ...

Asked for more details by the Dallas Morning News, Jones said he had stage 4 melanoma in 2010. At stage 4, cancer has spread ...

Dallas Cowboys owner Jerry Jones recently revealed to The Dallas Morning News that he had a battle with stage 4 cancer. The ...

MONTGOMERY, Texas — A Montgomery High School graduate is alive today thanks to his mother’s quick decision to take him to the emergency room after noticing what seemed like minor symptoms. That visit ...

A new trial found that lorazepam-based regimens helped control agitation and restlessness more than haloperidol alone, but ...

By the time Walter and Juliet Jacobs went to see Dr. Anil Potti, Juliet’s lung cancer was spreading through her torso. She ...

The Organization for Associate Degree Nursing (OADN) has named Sami Rahman, Director of Simulation and Clinical Laboratories for the Blinn College District, to its prestigious 2025 class of fellows of ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

A human trial showed promising results for the ELI-002 2P, which successfully targeted colorectal and pancreatic cancer tumors.